The Top Three Holders Of Yirendai Ltd. (YRD)

Yirendai Ltd. (NYSE:YRD) reached 122.63% versus a 1-year low price of $19.18. The stock was last seen -4.88% lower, reaching at $42.71 on 11/22/2017. At recent session, the prices were hovering between $41.51 and $44.5. This company shares are 4.14% off its target price of $44.48 and the current market capitalization stands at $2.5B. The recent change has given its price a -4.51% deficit over SMA 50 and -20.17% deficit over its 52-week high. The stock witnessed -15.89% declines, 16.33% gains and 83.45% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found YRD’s volatility during a week at 7.63% and during a month it has been found around 7.17%.

Yirendai Ltd. (YRD) Top Holders

Institutional investors currently hold around $235 million or 11.1% in YRD stock. Look at its top three institutional owners. Sylebra Hk Co Ltd owns $61.84 million in Yirendai Ltd., which represents roughly 2.47% of the company’s market cap and approximately 26.31% of the institutional ownership. Similar statistics are true for the second largest owner, Numeric Investors Llc, which owns 1,029,263 shares of the stock are valued at $46.21 million. The third largest holder is Schroder Investment Management Group, which currently holds $24.86 million worth of this stock and that ownership represents nearly 0.99% of its market capitalization.

Yirendai Ltd. 13F Filings

At the end of September reporting period, 46 institutional holders increased their position in Yirendai Ltd. (NYSE:YRD) by some 1,953,112 shares, 23 decreased positions by 807,090 and 4 held positions by 2,481,050. That puts total institutional holdings at 5,241,252 shares, according to SEC filings. The stock grabbed 24 new institutional investments totaling 580,814 shares while 11 institutional investors sold out their entire positions totaling 192,942 shares.

Yirendai Ltd. (YRD) Analyst Guide

Several analysts have released their opinion on Yirendai Ltd. (NYSE:YRD), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 1 strong sell ratings, collectively assigning a 2.25 average brokerage recommendation.

SHARE
Previous articleInstitutional investors now have $248 million stake in ZIOPHARM Oncology, Inc. (ZIOP)
Next articleBank Of New York Mellon Corp Now Holds $1.16 billion Worth Of Cerner Corporation (CERN)